Guggenheim Capital LLC Precigen, Inc. Transaction History
Guggenheim Capital LLC
- $14 Billion
- Q1 2024
Shares
3 transactions
Others Institutions Holding PGEN
# of Institutions
142Shares Held
145MCall Options Held
208KPut Options Held
43.7K-
Third Security, LLC83.5MShares$123 Million73.5% of portfolio
-
Patient Capital Management, LLC Baltimore, MD17.5MShares$25.7 Million1.27% of portfolio
-
Black Rock Inc. New York, NY10.4MShares$15.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.77MShares$9.95 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.03MShares$4.46 Million0.0% of portfolio
About PRECIGEN, INC.
- Ticker PGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 208,150,000
- Market Cap $306M
- Description
- Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...